Return to search

Redpin Therapeutics snags $15.5m

New York City-based Redpin Therapeutics, Inc., a chemogenetics company, has secured $15.5 million in funding.

New York City-based Redpin Therapeutics, Inc., a chemogenetics company, has secured $15.5 million in funding. The lead backers were 4BIO Capital and Arkin Bio Ventures.

Source: Press Release